Last reviewed · How we verify
NCT06613932
Assessment of L-PRF, Nanohydroxyapatite Combined With L-PRF Using Pulpotomy in Mature Mandibular First Molars
NA trial testing pulpotomy in Irreversible Pulpitis in 45 participants. Currently enrolling.
30 October 2024
Quick facts
| Lead sponsor | Future University in Egypt |
|---|---|
| Phase | NA |
| Status | Recruiting now |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | double |
| Primary purpose | treatment |
| Enrollment | 45 |
| Start date | 30 October 2023 |
| Primary completion | 30 October 2024 |
| Estimated completion | 30 October 2024 |
| Sites | 1 location across Egypt |
Drugs / interventions tested
- pulpotomy
Conditions studied
- Irreversible Pulpitis — all drugs for Irreversible Pulpitis →
Sponsor
Future University in Egypt
Who can join
Adults 15 to 30, any sex, with Irreversible Pulpitis. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
Clinical and Radiographic Assessment of L-PRF, Nanohydroxyapatite material combined with L-PRF scaffold in Vital pulp Therapy. Treatments in Mandibular First Molars with Closed Apices, Randomized Controlled Trial.
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT06613932
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of pulpotomy
Trials testing the same drug.
- NCT06640205 — Assessment of I-PRF Versus Nano MTA Combined with I-PRF Scaffold in Vital Pulp Therapy in Mature Mandibular First Molars · NA · recruiting
- NCT07332026 — Evaluation of the Effect of Type 2 Diabetes Mellitus on the Success of Adult Pulpotomy · NA · completed
- NCT05297344 — Clinical Study of the Direct Pulp Capping in Primary Teeth · NA · completed
- NCT03956199 — Pulpotomy vs.Root Canal Treatment in Managing Irreversible Pulpitis · NA · unknown
- NCT05427851 — Diode Laser Pulpotomy of Mature Permanent Molars With Irreversible Pulpitis · NA · unknown
Other recruiting trials for Irreversible Pulpitis
Currently open trials in the same condition.
- NCT07233564 — Comparison of Pain Between Supraperiosteal Injection of Dexamethasone Versus Placebo on Postoperative Pain in Teeth With · NA · active not recruiting
- NCT06843525 — Bite Force Measurements · recruiting
- NCT07163975 — Complete Pulpotomy and Root Canal Treatment Patients With Irreversible Pulpitis With Type 2 Diabetes Mellitus · NA · recruiting
- NCT07073573 — Evaluation of Pulpal Biomarkers in Vital Pulp Therapy · NA · active not recruiting
- NCT06730360 — Clinical and Radiographic Assessment of Photobiomodulated MTA Pulpotomy in Immature First Permanent Molars with Irrevers · NA · recruiting
Other Future University in Egypt trials
Trials by the same sponsor.
- NCT07347925 — Effect of Pre-Hospital ARNI Therapy on Short-Term Outcomes in HFrEF · recruiting
- NCT07129720 — Educational Program to Improve Dental Interns, Knowledge ,Attitude and Awareness Toward Molar Incisor Hypo-mineralizatio · NA · completed
- NCT07193342 — Effect of Computer-controlled vs. Conventional Injection on Pain and Anxiety in Children · NA · completed
- NCT06950762 — Aesthetic Performance of Two Injectable Resin Composites in Class V Cavities: A Randomized Clinical Trial · NA · not yet recruiting
- NCT06882343 — Performance of Bioactive Low Viscosity Composite in Deep Marginal Elevation Restorations · NA · not yet recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT06613932 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Future University in Egypt
- Last refreshed: 26 September 2024
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06613932.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing